← SynDRA
CIMATEROL
SynDRA canonical compound SYN0025140 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ADRB3 |
|---|
| Mechanism of action | Adrenergic receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- Adrenergic receptor agonist
- ADRB1 AGONIST
- ADRB2 AGONIST
- ADRB3 FULL AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- DRD2
- ADGRF1
- HRH3
- HTR1A
- HTR1E
- HTR2A
- HTR2C
- HTR6
- HTR7
- MPG
- MUTYH
- NEIL1
- NEIL2
- NTHL1
- OGG1
- OPRK1
- RGS4
- S1PR1
- SIGMAR1
- SLC6A2
- SLC6A3
- SMUG1
- TDG
- HRH4
- HRH2
- ADRA1A
- HRH1
- ADRA1B
- ADRA2A
- ADRA2C
- AGTR1
- APLNR
- C5AR1
- CHRM1
- CHRM3
- CHRM5
- CX3CR1
- DRD1
- DRD3
- DRD4
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
Cross-references
Synonyms
- AB-A-66
- AB-A 663
- ABA-663
- AC 263,780
- AC-263780
- cimatrol
- Cimaterolum
- AB-A-663
- ZPY8VRF0GB
- 2-amino-5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzonitrile
- CL-263,780
- DTXCID0025652
- 2-amino-5-(1-hydroxy-2-(propan-2-ylamino)ethyl)benzonitrile
- 5-(1-hydroxy-2-(isopropylamino)ethyl)anthranilonitrile
- RefChem:577139
- Cimater
- MFCD00209815
- 2-Amino-5-(1-hydroxy-2-(isopropylamino)ethyl)benzonitrile
- 2-Amino-5-[1-hydroxy-2-(isopropylamino)ethyl]benzonitrile
- NCGC00024589-02
- Cimaterolum [Latin]
- CL 263780;CL-263780;CL263780
- Cimaterol [USAN:INN]
- CAS-54239-37-1
- UNII-ZPY8VRF0GB
- BUXRLJCGHZZYNE-UHFFFAOYSA-N
- (+-)-5-(1-Hydroxy-2-(isopropylamino)ethyl)anthranilonitrile
- CIMATEROL [INN]
- CIMATEROL [MI]
- Cimaterol (USAN/INN)
- CIMATEROL [USAN]
- BSPBio_001582
- KBioGR_000302
- KBioSS_000302
- SCHEMBL250088
- BCBcMAP01_000252
- CHEBI:91807
- GTPL12578
Look up CIMATEROL in the interactive SynDRA portal →